Novel Treatment for Dental Ankylosis
Launched by RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY · Jan 14, 2023
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring new treatment methods for a dental condition called dental ankylosis, where a tooth becomes fused to the bone, preventing normal growth and development in the jaw. The study aims to find out if one or two innovative approaches can help improve the situation for patients aged 6 to 30 who have been diagnosed with either a baby tooth or a certain type of permanent tooth that is mildly to moderately affected by ankylosis.
To be eligible for this trial, participants must be willing to follow the study guidelines and provide informed consent. They should be able to speak English and have a clinically diagnosed case of dental ankylosis, which will be confirmed through specific dental examinations. If someone joins the study, they can expect to be closely monitored during the treatment process, which may involve orthodontic techniques. Importantly, the trial is currently recruiting participants, and it’s a chance for individuals facing this dental issue to contribute to finding potential solutions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Full informed consent and/or informed assent (minors)
- • Be willing and able to comply with all study requirements
- • Male or female
- • Aged 6-30
- • Clinically diagnosed to have either an ankylosed deciduous tooth or a non-third molar mildly- to moderately- ankylosed permanent tooth, and with crown partially visible in the oral cavity. Clinical diagnosis of ankylosis includes the following factors: dental trauma history, infra-eruption with no apparent mechanical obstruction or other cause, contralateral tooth in occlusal contact for over one year, decreased alveolar bone height, no or reduced tooth mobility, and x-ray or cone-beam computer tomography (CBCT) imaging indications of an obliterated PDL space. Ultimately, the diagnosis will be confirmed by lack of tooth movement discovered during orthodontic treatment or when subjected to a heavy force through our study (Phelan M K, et al. 1990).
- • English speaking (primary language or fluent)
- Exclusion Criteria:
- • Severe and extensive ankylosis of permanent teeth as diagnosed through CBCT
- • Primary failure of eruption with previous orthodontic treatment
- • Any systemic disorders particularly those affecting bleeding or skeletal health
- • Any systemic medications
- • Any mental or developmental disorders that affect patient understanding or compliance
- • Allergic to our local anesthetic drug
- • Can pass an infectious disease to someone else right now (e.g., having a flu)
- • Is pregnant
- • Has a history of smoking
- • Have not reached the age of 6 or older than age of 30
- • Not cooperative enough during dental examinations
- • The dentist finds out that he/she is not able to keep the mini-implant, the brackets and the wires in place around the tooth that is being treated
- • Not fluent in English
About Rutgers, The State University Of New Jersey
Rutgers, The State University of New Jersey, is a prestigious public research university renowned for its commitment to advancing medical science and public health. As a leading clinical trial sponsor, Rutgers leverages its extensive academic resources, cutting-edge facilities, and a diverse team of experts to conduct innovative research that addresses critical health challenges. The university fosters collaboration across disciplines, engaging in partnerships with healthcare institutions and industry leaders to enhance the development of novel therapies and improve patient outcomes. With a strong emphasis on ethical standards and regulatory compliance, Rutgers is dedicated to advancing clinical knowledge while prioritizing participant safety and well-being in all of its research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newark, New Jersey, United States
Patients applied
Trial Officials
Wei Huang, DDS, PhD
Principal Investigator
Rutgers School of Dental Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials